Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
Patents for C07C 243 - Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes (2,826)
03/2006
03/21/2006CA2181366C Hydrogenation catalyst, process for the preparation thereof and hydrogenation process
03/09/2006WO2005116640A3 Identification of anti-prion drugs by high-throughput screening based on sift
03/09/2006US20060052588 Novel nitrosation polymer in organic synthesis
03/08/2006EP1039902B1 Inhibitors of gap junction communication
03/07/2006US7009065 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere
03/01/2006EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
02/2006
02/23/2006US20060041024 Polycationic compounds and uses thereof
02/22/2006CN1737005A Chiral diphosphor compound an transition metal complex thereof
02/15/2006CN1241905C Stabilization of n-nitrosohydroxylamines by use of absorptive material
02/08/2006EP1149082B1 Process for preparing pesticidal intermediates
02/02/2006WO2005123660A3 Polycationic compounds and uses thereof
02/01/2006EP1463707A4 A group of novel anti-cancer compounds with specific structure
01/2006
01/31/2006US6992221 Production of commercial herbicides: carbonylating an amidrazone of formula (A) with one or more carbonylating agent, or by (ii) condensing a hydrazonoyl derivative of formula (A) with one or more ring-forming agent, wherein
01/26/2006US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
01/25/2006CN1724512A Method of synthesizing hydrodiazo kind compound
01/18/2006CN1721394A Process for preparing diazanyl ethyl acetate hydrochloride
01/12/2006DE102004031100A1 Anthranilamide Anthranilamides
01/12/2006DE102004030987A1 Ortho-substituierte (3-Hydroxyphenyl)-essigsäure-benzyliden-hydrazide Ortho-substituted (3-hydroxyphenyl) -acetic acid benzylidene-hydrazide
01/05/2006WO2006000836A1 Process for the preparation of anastrozole
01/05/2006WO2006000294A1 Novel diazeniumdiolate compounds, process for the preparation thereof, and therapeutic use thereof
01/05/2006CA2547979A1 Process for the preparation of anastrozole
01/04/2006EP1363873A4 Peptide deformylase inhibitors
01/04/2006CN1234682C Preparation method of high pure 1,1-dimethyl hydrazine
01/03/2006US6982286 Bicarbocyclic hydrazine/hydrazide compounds as inhibitors of semicarbazide-sensitive amine oxidases (SSAO), treat an inflammatory disease or condition, a disease related to carbohydrate metabolism, smooth muscle cell function
12/2005
12/29/2005WO2005123660A2 Polycationic compounds and uses thereof
12/29/2005WO2005123646A2 Fluoroorganic compounds and anti-fouling treatments
12/29/2005US20050288525 Reagents for asymmetric allylation, aldol, and tandem aldol and allylation reactions
12/29/2005US20050288523 Chiral diphosphorus compounds and transition metal complexes thereof
12/29/2005CA2570248A1 Polycationic compounds and uses thereof
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005CN1714079A Mandelic acid derivatives
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/22/2005WO2005069741A3 Process for producing simvastatin using novel hydrazide intermediates
12/22/2005US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/14/2005EP1603860A2 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
12/14/2005EP1603858A2 Kcnq channel modulating compounds and their pharmaceutical use
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005DE102004022900A1 Chirale Diphosphorverbindungen und deren Übergangsmetallkomplexe Chiral diphosphorus and their transition metal complexes
12/08/2005DE102004022898A1 Chirale Diphosphinoterpene und deren Übergangsmetallkomplexe Chiral Diphosphinoterpene and their transition metal complexes
12/07/2005EP1601642A2 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005EP1601384A1 Methods of radiofluorination of biologically active vectors
12/07/2005CN1704421A Cirality diphosphaneterpene and transition metal complex thereof
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/01/2005US20050267316 Chiral diphosphinoterpenes and transition metal complexes thereof
11/2005
11/30/2005CN1703396A Novel propargylether derivatives for controlling phytopathogenic microorganisms
11/30/2005CN1229336C Photoactive compound used as intermediate for preparing photoactive 2-imidazoline-5-ketone or 2-imdazoline-5-thio-ketone derivative
11/29/2005CA2420329C Sulphonylaminocarbonyltriazolinones
11/29/2005CA2413021C Process for selective decomposition of hydrazine in a hydrazine/hydrazine substitute/water mixture
11/23/2005CN1228328C Pesticide intermediate compound
11/17/2005WO2005108349A2 Process for preparing atazanavir bisulfate and novel forms
11/17/2005WO2005108347A2 Substituted enaminones, their derivatives and uses thereof
11/17/2005US20050256202 reacting a solution of atazanavir in acetone solvent with a concentrated sulfuric acid; need to add the seeds of Form A crystals of atazanavir bisulfate to the reaction mixture; salt formation; Form A crystals; HIV protease inhibitor
11/17/2005US20050256116 Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/17/2005CA2777216A1 Process for preparing atazanavir bisulfate and novel forms
11/16/2005EP1595886A1 Chiral diphosphinoditerpenes and their transition metals complexes
11/16/2005EP1595885A2 Chiral diphosphorus compounds and their transition metal complexes
11/15/2005US6965040 Photogenerated reagents
11/02/2005EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments
11/01/2005US6960664 Aza hydroxylated ethyl amine compounds
11/01/2005US6960355 Modified amino acid compounds useful in delivery of active agents
10/2005
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005CN1688539A Improved syntheton synthesis
10/26/2005CN1224598C Naphthalene derivatives
10/20/2005US20050234253 bidentate organophosphorous ferrocenyl ligands that create a highly asymmetric coordination sphere
10/20/2005US20050234020 e.g. 3'-(1-Cyclohexyl-5-hydroxy-3-methyl-1H-pyrazol-4-ylazo)-2'-hydroxy-biphenyl-3- carboxylic acid; agonists of TPO receptor; non-peptide; thrombocytopenia is due to bone marrow, stem cell, or liver transplant, idiopathic thrombocytopenia purpura, myelodysplastic syndromes, aplastic anemia or leukemia
10/19/2005CN1223587C Process for producing substituted aniline compound
10/12/2005CN1680368A Process for production of substituted aniline compound
10/06/2005US20050222419 Process for preparing pesticidal intermediates
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222243 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/05/2005CN1221504C Perfluoroisopropylbenzene derivatives
10/04/2005CA2094397C Homobifunctional agents for coupling enzymes and the like to antibodies and the like
09/2005
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005US20050209283 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
09/21/2005EP1577328A1 Polymer-immobilized formamides, catalysts containing the same and allylation process
09/21/2005EP1575911A2 Biaromatic compounds which activate ppar-gamma type receptors, and use thereof in cosmetic or pharmaceutical compositions
09/21/2005CN1219752C Process for preparing substituted hydrazide by using carboxylic acid
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203096 Compounds to treat Alzheimer's disease
09/14/2005EP1572630A1 Antibacterial agents
09/09/2005WO2005082840A1 Process for the allylation of n-acylhydrazones
09/07/2005CN1217920C Compounds to treat Alzheimer disease
09/06/2005US6939882 Fungicides
09/01/2005WO2005080319A1 Hydrazino alcohol derivatives useful as inhibitors of copper-containing amine oxidases
08/2005
08/31/2005EP1567498A2 Mandelic acid derivatives
08/31/2005EP1483276B1 Ferrocenyl ligands and the use thereof in catalysis
08/31/2005CN1216533C Ectoparasitic insect pest controllers for animals and their usage
08/25/2005WO2005078157A1 Antirust composition
08/25/2005US20050186176 Compounds and compositions for delivering active agents
08/24/2005EP1299349B1 Compounds to treat alzheimer's disease
08/17/2005CN1656057A N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
08/04/2005WO2005070871A2 Amino alcohol derivatives and their activity as renin inhibitors
08/04/2005WO2005069741A2 Process for producing simvastatin using novel hydrazide intermediates
08/04/2005CA2553840A1 Amino alcohol derivatives and their activity as renin inhibitors
08/03/2005CN1649831A Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
08/03/2005CN1649830A Substituted aryl ketones
08/03/2005CN1213020C Phenylalaninol derivatives
07/2005
07/27/2005EP1556390A2 Functionalized ionic liquids, and methods of use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 ... 29